Home / Market News / $MGRX

$MGRX news and market catalysts

The 9 most recent market catalysts affecting $MGRX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

9 catalysts 3 high impact 5 bullish 1 bearish Healthcare
Oct 9, 2026 Corporate Catalyst Neutral Impact 65
Mangoceuticals Closes Registered Direct Offering Following $2.5M Strategic Investment Commitment In MangoRx IP Holdings To Support Intellectual Property Commercialization
Mangoceuticals (MGRX) announced the closing of a registered direct offering, which provides additional working capital to the parent company. This is significant as it injects capi…
Oct 2, 2026 Corporate Catalyst Bearish Impact 65
Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why
Mangoceuticals (MGRX) saw its shares fall 12% after hours, even though its former subsidiary, MangoRx IP Holdings, secured a $2.5 million strategic investment. This investment, str…
Oct 1, 2026 Corporate Catalyst Neutral Impact 65
Mangoceuticals’ MangoRx IP Secures $2.5M Investment From Strategic Investors, Receives Initial $1.75M Tranche
Mangoceuticals announced that its subsidiary, MangoRx IP, received a $1.75 million initial tranche of a $2.5 million investment from strategic investors, in exchange for a 25% memb…
Aug 21, 2026 Corporate Catalyst Neutral Impact 85
On Aug 19, Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement; Pipe Financing Minimum Of $15M Not Raised By Aug 21, 2026; Closing Conditions Not Met
Mangoceuticals and Nuclea Energy have terminated their business combination agreement because they failed to secure the minimum $15 million PIPE financing by the August 21, 2026 de…
Aug 13, 2026 Corporate Catalyst Bullish Impact 75
Mangoceuticals’ Merger Partner, Nuclea Energy, Enters Into Definitive Agreement With Moltex Energy To Acquire Advanced Nuclear Technology Assets; Terms Undisclosed
Nuclea Energy, Mangoceuticals' merger partner, has entered a definitive agreement to acquire advanced nuclear technology assets from Moltex Energy, which is in administration. This…
Aug 6, 2026 Corporate Catalyst Bullish Impact 85
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why
Mangoceuticals (MGRX) experienced a significant after-hours jump due to a key development related to its pending merger with Nuclea Energy. Nuclea Energy USA Inc., a subsidiary of …
Aug 5, 2026 Corporate Catalyst Bullish Impact 65
Mangoceuticals' Merging Partner's Subsidiary Nuclea Energy USA Inks MoU With Utah To Mull Siting Of Nuclear Test Reactor
Nuclea Energy USA, a subsidiary of Mangoceuticals' merger partner, has signed a Memorandum of Understanding with the State of Utah to explore the siting of a nuclear test reactor. …
Aug 4, 2026 Corporate Catalyst Bullish Impact 65
Mangoceuticals Receives An Additional 180-Calendar-Day Extension From The Nasdaq To Regain Compliance With The Minimum Bid Price Requirement
The extension from Nasdaq provides Mangoceuticals (MGRX) with additional time to meet the minimum bid price requirement, averting immediate delisting. This is a neutral development…
Jul 31, 2026 Corporate Catalyst Bullish Impact 95
Mangoceuticals (MGRX) Stock Jumps 138% After Hours On Nuclear Reactor Deal: Here's Why It Is Trending
Mangoceuticals, a public health and wellness company, is undergoing a dramatic transformation by acquiring Nuclea Energy Inc., a developer of lead-cooled microreactors. This move r…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.